ALR Technologies Announces Mac OS Compatibility for the Health-e-Connect System
Mac Users Can Now Track Their Blood Glucose Trends Online Using Health-e-Connect
RICHMOND, VA--(Marketwired - Apr 22, 2014) - ALR Technologies (OTCBB: ALRT) announced today that its blood glucose data extraction and upload software is now available for Mac OSX 10.7 and newer Operating Systems. Patients are now able to install ALRT's software onto their Mac computers, upload the blood glucose data from their meters1, and have their data trends tracked online by ALRT's Diabetes Care Facilitators and other members of a patient's care team.
Get the ALRT software
Mac compatibility represents a significant opportunity for many Mac-using patients with diabetes, as monitoring software for some of the major glucose meters brands is compatible only with Windows-based computers. The ALRT Mac-friendly software will now be an option for patients with the following brands of meter: LifeScan, Nipro, Bayer, Abbott and Roche.
ALR Technologies CEO Sidney Chan commented: "There is universal agreement that patients and their care teams need to make better use of the valuable data stored in their glucose meters. We hope that ALRT has provided a valuable service by making it possible for Mac users to utilize their computers in the management of diabetes."
Patients will need an ALRT data cable to upload their glucose meters. To get the ALRT data cable, you may contact us at email@example.com.
Check out the list of compatible meters and the connection requirements
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to meet their diabetes goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities and Exchange Commission.
For more information, email us at